Functional analysis of tuberin by using animal models of tumor suppressor Tsc2-mutant.
Functional analysis of tuberin by using animal models of tumor suppressor Tsc2-mutant.
批准号:
14580804
负责人:
KOBAYASHI Toshiyuki
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
将Tsc 2(结节性硬化症2基因)cDNA的表达载体导入Tsc 2缺陷型小鼠肾肿瘤(RT)细胞系(MKOC 1.-MKOC 2)中。277)并建立了表达块茎蛋白的稳定细胞系(T2细胞)。与空载体的对照细胞系相比,T2细胞中p70 S6激酶(S6 K)的磷酸化被抑制。结球蛋白表达可抑制RC细胞在裸鼠体内的成瘤潜能。给予雷帕霉素(一种mTOR抑制剂)也阻断了RC细胞的肿瘤发生。这些结果提示mTOR β S6 K通路在Tsc 2-突变引起的肿瘤发生中具有一定的作用。有趣的是,Erc mRNA(间皮素基因同源物)的表达在T2细胞中也被抑制。与此相反,雷帕霉素处理亲本MKOC 1 -277细胞没有改变Erc mRNA的表达水平。这些结果表明Erc受tuberin下游信号通路的调控,而不依赖于mTOR β 6 K。这种新的tuberin调节通路可能成为结节性硬化症治疗的新的候选分子靶点。为了寻找调节Erc表达的途径,用各种刺激物或信号转导途径的化学抑制剂和活化剂处理Hela细胞,并通过北方和Western印迹分析进行分析。在血清饥饿的情况下,氨基末端的Erc蛋白的一半增加,可能是由蛋白酶介导的切割。因此,Erc蛋白的表达和功能可能受到与细胞生长相关的翻译后水平的调节。在这项研究中,还进行了候选的tuberin结合蛋白的搜索。以含有Rapt-GAP同源结构域的tuberin羧基端为诱饵,通过双杂交技术鉴定了gamma-adaptin和myomegalin。
英文摘要
Expression vector for Tsc2 (tuberous sclerosis 2 gene) cDNA was introduced in Tsc2-deficient mouse renal tumor (RT) cell line (MKOC1.-277) and stable lines expressing tuberin (T2 cells) were established. Phosphorylation of p70 S6 kinase (S6K) was suppressed in T2 cells as compared with control cell lines with empty vector. Tumorigenic potential of RC cells in the nude mouse was suppressed by tuberin expression. Administration of rapamycin, a mTOR inhibitor, also blocked tumorigenesis of RC cells. These results suggest that mTOR〜S6K pathway has some role in tumorigenesis caused by Tsc2-mutation. Interestingly, expression of Erc mRNA (mesothelin gene homologue) was also suppressed in T2 cells. In contrast, rapamycin treatment of parental MKOC1-277 cells did not change expression level of Erc mRNA. These results suggest that Erc is regulated by downstream signaling pathway of tuberin, which is independent of mTOR〜S6K. This novel tuberin-regulated pathway may be a new candidate for therapeutic molecular target for tuberous sclerosis. To search for pathways regulating Erc expression, Hela cells were treated with various stimuli or chemical inhibitors and activators of signal transduction pathways and analyzed by northern and western blot analyses. In the case of serum starvation, amino-terminal half of Erc protein was increased, probably by protease-mediated cleavage. Thus, expression and function of Erc protein may be regulated by post-translational level in relation with cell growth. In this study, search for candidates of tuberin-binding protein was also performed. Gamma-adaptin and myomegalin were identified by two-hybrid analysis using carboxy-terminal region of tuberin containing Rapt-GAP homology domain as a bait.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Satake, N., et al.: "N-Ethyl-N-hydroxyethyinitrosamine(EHEN)-induced renal and hepatocarcinogenesis in the tumor suppressor Tsc2 transgenic rat"Cancer Lett.. 184. 157-163 (2002)
Satake,N.等人:“肿瘤抑制基因 Tsc2 转基因大鼠中 N-乙基-N-羟基乙基亚硝胺 (EHEN) 诱导的肾癌和肝癌发生”Cancer Lett.. 184. 157-163 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Honda, S., et al.: "Ets protein Elf-I bidirectionally suppresses transcriptional activities of the tumor suppressor Tsc2 gene and the repair-related Nth1 gene."Molecular Carcinogenesis. 37(3). 122-129 (2003)
Honda, S. 等人:“Ets 蛋白 Elf-I 双向抑制肿瘤抑制基因 Tsc2 基因和修复相关 Nth1 基因的转录活性。”分子癌发生。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hino, O., et al.: "Renal carcinogenesis : Genotype, phenotype and dramatype."Cancer Sci.. 94. 142-147 (2003)
Hino, O., 等人:“肾癌发生:基因型、表型和戏剧型。”Cancer Sci.. 94. 142-147 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Adachi, H., et al.: "Niban gene is commonly expressed in the renal tumors : a new candidate marker for renal carcinogenesis."Oncogene. 23(in press). (2004)
Adachi, H. 等人:“Niban 基因通常在肾肿瘤中表达:肾癌发生的新候选标记。”癌基因。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kobayashi, T. et al.: "Toward chemotherapy for Tsc2-mutant renal tumor."Proc.Jpn.Acad.. 79. 22-25 (2003)
Kobayashi, T. 等人:“针对 Tsc2 突变肾肿瘤的化疗。”Proc.Jpn.Acad.. 79. 22-25 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Analysis of minimal representations and branching laws of infinite-dimensional representations
-
批准号:22340026
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.57万
-
财政年份:2010
-
负责人:KOBAYASHI Toshiyuki
-
依托单位:
Elucidation of signal transduction systems which are regulated by BHD tumor suppressor protein
-
批准号:20590316
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:KOBAYASHI Toshiyuki
-
依托单位:
Transformation groups for geometric structures, global geometric analysis, and theory of branching laws of infinite dimensional representations
-
批准号:18340037
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.56万
-
财政年份:2006
-
负责人:KOBAYASHI Toshiyuki
-
依托单位:
Elucidation of tumor suppressor function of Birt-Hogg-Dube syndrome gene(BHD)
-
批准号:18590380
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:KOBAYASHI Toshiyuki
-
依托单位:
Abnormality of sugar/amino acid transport and ATP sensor in renal carcinogenesis
-
批准号:16590256
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:KOBAYASHI Toshiyuki
-
依托单位:
Theory of branching laws of unitary representations and non-commutative harmonic analysis by transformation groups of geometric structures
-
批准号:14340043
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.82万
-
财政年份:2002
-
负责人:KOBAYASHI Toshiyuki
-
依托单位:
Functional analysis of hamartin by use of Tscl knockout mice.
-
批准号:12680819
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:KOBAYASHI Toshiyuki
-
依托单位:
Theory of branching laws of unitary representations of reductive Lie groups and geometric realization of representations
-
批准号:11440018
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.39万
-
财政年份:1999
-
负责人:KOBAYASHI Toshiyuki
-
依托单位:
Functional analysis of Tsc2 gene product by conditional gene targeting.
-
批准号:10680783
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1998
-
负责人:KOBAYASHI Toshiyuki
-
依托单位:
Generation of the wild-type Tsc2 transgenic Eker rat and its effect on renal carcinogenesis.
-
批准号:08680915
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1996
-
负责人:KOBAYASHI Toshiyuki
-
依托单位:
海外基金